XML 83 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Information (Tables)
6 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Disaggregation of Revenue [Table Text Block]
 
Three Months Ended December 31,
(in millions)
2019
 
2018
Pharmaceutical Distribution and Specialty Solutions (1) (2)
$
35,501

 
$
33,534

Nuclear and Precision Health Solutions
213

 
206

Pharmaceutical segment revenue
35,714

 
33,740

Medical distribution and products (3)
3,498

 
3,527

Cardinal Health at-Home Solutions
525

 
479

Medical segment revenue
4,023

 
4,006

  Total segment revenue
39,737

 
37,746

Corporate (4)
(2
)
 
(6
)
Total revenue
$
39,735

 
$
37,740

 
Six Months Ended December 31,
(in millions)
2019
 
2018
Pharmaceutical Distribution and Specialty Solutions (1) (2)
$
68,713

 
$
64,742

Nuclear and Precision Health Solutions
429

 
413

Pharmaceutical segment revenue
69,142

 
65,155

Medical distribution and products (3)
6,944

 
6,907

Cardinal Health at-Home Solutions
996

 
900

Medical segment revenue
7,940

 
7,807

  Total segment revenue
77,082

 
72,962

Corporate (4)
(6
)
 
(9
)
Total revenue
$
77,076

 
$
72,953


(1)
Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services."
(2)
Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(3)
Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.
(4)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following tables present revenue by geographic area:
 
Three Months Ended December 31,
(in millions)
2019
 
2018
United States
$
38,670

 
$
36,716

International
1,067

 
1,030

  Total segment revenue
39,737

 
37,746

Corporate (1)
(2
)
 
(6
)
Total revenue
$
39,735

 
$
37,740

 
Six Months Ended December 31,
(in millions)
2019
 
2018
United States
$
74,980

 
$
70,960

International
2,102

 
2,002

  Total segment revenue
77,082

 
72,962

Corporate (1)
(6
)
 
(9
)
Total revenue
$
77,076

 
$
72,953

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
 
Three Months Ended December 31,
(in millions)
2019
 
2018
Pharmaceutical
$
462

 
$
443

Medical
195

 
188

Total segment profit
657

 
631

Corporate
(323
)
 
(127
)
Total operating earnings
$
334

 
$
504

 
Six Months Ended December 31,
(in millions)
2019
 
2018
Pharmaceutical
$
860

 
$
851

Medical
365

 
323

Total segment profit
1,225

 
1,174

Corporate
(6,155
)
 
146

Total operating earnings/(loss)
$
(4,930
)
 
$
1,320


Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
December 31,
2019
 
June 30,
2019
Pharmaceutical
$
23,143

 
$
22,446

Medical
15,490

 
15,284

Corporate
2,409

 
3,233

Total assets
$
41,042

 
$
40,963